The first drug has arrived in the Indian market for the treatment of Coronavirus treatment. Glenmark Pharmaceuticals has been given permission to manufacture and market the antiviral drug Favipiravir for Covid-19.
The company makes this drug under the name of FabiFlu. A full strip of 34 tablets will be available for Rs 3,500 i.e. a tablet will cost around Rs 103. The drug FabiFlu will be used to treat patients with mild to moderate symptoms. It will be found in drug hospitals and medical stores at prescription. Let us know how it works.
The clinical trial was conducted by Glanmark on 90 patients with mild symptoms and 60 patients with moderate symptoms. This drug penetrates into the patient’s cells and prevents the virus from copying itself to reduce the viral load. That is, this drug is effective in preventing the spread of virus in the body in the initial stage of infection.